| Name | Title | Contact Details |
|---|---|---|
Edward Ryan |
Sr. Dir, IT, Office of CIO | Profile |
Annlea Rumfola |
EVP, Chief Information Officer | Profile |
Heather Knight |
Chief Operating Officer | Profile |
Chris Toth |
Chief Executive Officer | Profile |
Carl Jenkins |
Associate General Counsel, Legal-Regulatory | Profile |
StemCyte, Inc is a Covina, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.
Twine Health is new kind of healthcare technology company that takes a person-centric approach to collaborative care. Most patient-centric paradigms are infected by the age-old assumption that patients are their conditions, and carry the hubris that patients can be "fixed" by throwing resources at them. To us, patients are people, not numbers. We strive to give them tools to easily understand and manage their unique health situation, and enhance relationships with their care teams.
Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by InterWest Partners, Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.
CCA Medical is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.